The new agentic code converter uses Genie Code-powered agents to analyze, translate, validate, and refine SQL workloads ...

Recursive’s $410 million outlay represents the bulk of the company’s fundraising to date— but on a call with TechCrunch, ...

Marshawn Kneeland, the former Dallas Cowboys defensive end who died by suicide last November, has been diagnosed with Stage 1 chronic traumatic encephalopathy (CTE) by Boston University researchers.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The family of former Dallas Cowboys defensive end Marshawn Kneeland has ...

The revelation of former Dallas Cowboys defensive end Marshawn Kneeland's chronic traumatic encephalopathy (CTE) diagnosis on July 7 provided a tragic epilogue to the story of his death by suicide in ...

The diagnosis comes eight months after Marshawn Kneeland died. Cooper Neill / Getty Images Boston University researchers diagnosed former Dallas Cowboys defensive end Marshawn Kneeland, who died in ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

RSI is also defined as an “AI system capable of fully autonomously designing and developing its own successor,” per Anthropic’s blog post. “We are not there yet, and recursive self-improvement is not ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Claude Lemieux’s brain is being donated to the Boston University CTE Center to research the long-term effects of repetitive brain injuries, his family said Saturday in a statement released by daughter ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...